| Antibiotics in the clinical pipeline in 2013 MS Butler, MA Blaskovich, MA Cooper The Journal of antibiotics 66 (10), 571-591, 2013 | 431 | 2013 |
| Antibiotics in the clinical pipeline at the end of 2015 MS Butler, MAT Blaskovich, MA Cooper The Journal of antibiotics 70 (1), 3-24, 2017 | 259 | 2017 |
| Unusual amino acids in medicinal chemistry MAT Blaskovich Journal of medicinal chemistry 59 (24), 10807-10836, 2016 | 162 | 2016 |
| Glycopeptide antibiotics: back to the future MS Butler, KA Hansford, MAT Blaskovich, R Halai, MA Cooper The Journal of Antibiotics 67 (9), 631-644, 2014 | 142 | 2014 |
| Synthesis of a chiral serine aldehyde equivalent and its conversion to chiral. alpha.-amino acid derivatives MA Blaskovich, GA Lajoie Journal of the American Chemical Society 115 (12), 5021-5030, 1993 | 113 | 1993 |
| Drug discovery and protein tyrosine phosphatases MAT Blaskovich Current medicinal chemistry 16 (17), 2095-2176, 2009 | 111 | 2009 |
| Contribution of amphipathicity and hydrophobicity to the antimicrobial activity and cytotoxicity of β-hairpin peptides IA Edwards, AG Elliott, AM Kavanagh, J Zuegg, MAT Blaskovich, ... ACS infectious diseases 2 (6), 442-450, 2016 | 100 | 2016 |
| Helping chemists discover new antibiotics MAT Blaskovich, J Zuegg, AG Elliott, MA Cooper ACS infectious diseases 1 (7), 285-287, 2015 | 100 | 2015 |
| Stereoselective synthesis of threo and erythro β-hydroxy and β-disubstituted-β-hydroxy α-amino acids MA Blaskovich, G Evindar, NGW Rose, S Wilkinson, Y Luo, GA Lajoie The Journal of Organic Chemistry 63 (11), 3631-3646, 1998 | 100 | 1998 |
| Antimicrobial silver in medicinal and consumer applications: a patent review of the past decade (2007–2017) W Sim, RT Barnard, MAT Blaskovich, ZM Ziora Antibiotics 7 (4), 93, 2018 | 86 | 2018 |
| Quinolone antibiotics TDM Pham, ZM Ziora, MAT Blaskovich Medchemcomm 10 (10), 1719-1739, 2019 | 76 | 2019 |
| Activity and predicted nephrotoxicity of synthetic antibiotics based on polymyxin B A Gallardo-Godoy, C Muldoon, B Becker, AG Elliott, LH Lash, JX Huang, ... Journal of medicinal chemistry 59 (3), 1068-1077, 2016 | 76 | 2016 |
| Recent discovery and development of protein tyrosine phosphatase inhibitors HO Kim, MA Blaskovich Expert Opinion on Therapeutic Patents 12 (6), 871-905, 2002 | 73 | 2002 |
| Developments in glycopeptide antibiotics MAT Blaskovich, KA Hansford, MS Butler, ZG Jia, AE Mark, MA Cooper ACS infectious diseases 4 (5), 715-735, 2018 | 66 | 2018 |
| Clostridium difficile Drug Pipeline: Challenges in Discovery and Development of New Agents AM Jarrad, T Karoli, MAT Blaskovich, D Lyras, MA Cooper Journal of medicinal chemistry 58 (13), 5164-5185, 2015 | 65 | 2015 |
| Highly efficient and versatile synthesis of libraries of constrained β-strand mimetics CO Ogbu, MN Qabar, PD Boatman, J Urban, JP Meara, MD Ferguson, ... Bioorganic & medicinal chemistry letters 8 (17), 2321-2326, 1998 | 63 | 1998 |
| Nitroimidazoles: molecular fireworks that combat a broad spectrum of infectious diseases CW Ang, AM Jarrad, MA Cooper, MAT Blaskovich Journal of medicinal chemistry 60 (18), 7636-7657, 2017 | 59 | 2017 |
| Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis AM Jarrad, A Debnath, Y Miyamoto, KA Hansford, R Pelingon, MS Butler, ... European journal of medicinal chemistry 120, 353-362, 2016 | 54 | 2016 |
| Evaluation of biomarkers for in vitro prediction of drug‐induced nephrotoxicity: comparison of HK‐2, immortalized human proximal tubule epithelial, and primary cultures of … JX Huang, G Kaeslin, MV Ranall, MA Blaskovich, B Becker, MS Butler, ... Pharmacology research & perspectives 3 (3), e00148, 2015 | 54 | 2015 |
| Mucin binding reduces colistin antimicrobial activity JX Huang, MAT Blaskovich, R Pelingon, S Ramu, A Kavanagh, AG Elliott, ... Antimicrobial agents and chemotherapy 59 (10), 5925-5931, 2015 | 53 | 2015 |
Matthew A. CooperUniversity of QueenslandVerified email at uq.edu.au
